A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the tolerance and safety of cinobufacini injection intraperitoneal treatment on
digestive system cancer patients with malignant ascites, and propose dosage regimens for
future clinical trials. The clinical trial is divided into two parts, including single and
successive administration.
Phase:
Phase 1
Details
Lead Sponsor:
Dongfang Hospital Affiliated to Beijing University of Chinese Medicine Dongfang Hospital Beijing University of Chinese Medicine